IFF Appoints Two New Fine Fragrance Perfumers
Get Alerts IFF Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -2.9%
Join SI Premium – FREE
"We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said
"IFF is a unique fragrance house that clearly defines the perfumer as an artist," said Carlin. "I'm thrilled to join IFF and explore new olfactory languages with its unique palette of ingredients, in a company that values profound human connections."
"This marks a significant milestone in my career," said Lee. "I'm honored to join such a fantastic, creative team and explore an extensive palette of ingredients at a company where its international reach is reflected in its very name."
With these appointments, IFF continues to strengthen its
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Contact:
VP, Communication and Branding, Scent
+33630097462
[email protected]
SOURCE IFF
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 49NORTH RELEASES GLOBAL PROCEDURE DESIGNER, A PROVEN INSTRUMENT FLIGHT PROCEDURE DESIGN SOLUTION REFRESHED FOR COMPLIANCE WITH LATEST REGULATIONS
- Xthings and ULTRALOQ to Showcase Dealer-Ready Smart Access Solutions at ALOA 2026
- Hartwig Medical Foundation and Ultima Genomics Expand Collaboration to Advance Whole-Genome Sequencing in Oncology Care
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share